NCT00607633View on ClinicalTrials.gov

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

CompletedOBSERVATIONAL
Enrollment

686

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

October 31, 2007

Conditions
Essential HypertensionLeft Ventricular Hypertrophy
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY